Superior non-GLP toxicology models.

When still at the early stage, certain toxicology studies can be exempted from GLP regulations. The main advantage of running non-GLP toxicology studies is to mitigate the risk of failure at the preclinical level, before deciding whether to push a study forward or to terminate it. Designing a study that meets the needs of your program and accurately analyzes the potential toxicologic risks of your compound requires deep knowledge and expertise in pharmacology and toxicology.

A knowledge we proudly have at PharmaLegacy. You can keep scrolling to check out our non-GLP toxicology models, and if you can’t find what you’re looking for, rest assured – we make custom made models!

Contact Us
Non-GLP Toxicology


The capability to Succeed:

  • 43,000 square feet of vivarium space
  • Scientific staff average over 15 years of pharmacology experience
  • 600+ validated animal models of disease spanning 40+ diseases
  • 150,000 square feet of facility space

Choose quality above all. Choose PharmaLegacy.

Contact Us

We’re ready when you are.

Tell us your pharmacology challenges.